Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
Pick Your Favored pizza beating- Instructions to Explore the Universe of Vehicle Leases
- Zelensky confidant dismissed from further posts amid bribery scandal
- What we know about Jonathan Ross, the ICE agent who shot and killed Renee Nicole Good in Minneapolis
- The most effective method to Decide the Best Auto Crash Attorney for Your Lawful Necessities
- Figure out How to Involve a Brain science Certification in Showcasing
- Step by step instructions to Get a good deal on Your Rooftop Substitution Venture
- Israel, Gulf states report fresh missile and drone attacks
- Affordable Care Act enrollment is slightly ahead of last year, despite expiring subsidies
